75 related articles for article (PubMed ID: 24939361)
1. GW0742 reduces mast cells degranulation and attenuates neurological impairments via PPAR
Lu W; Huang J; Flores J; Li P; Wang W; Liu S; Zhang JH; Tang J
Exp Neurol; 2024 Feb; 372():114615. PubMed ID: 37995951
[TBL] [Abstract][Full Text] [Related]
2. Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression.
Sng MK; Chan JSK; Teo Z; Phua T; Tan EHP; Wee JWK; Koh NJN; Tan CK; Chen JP; Pal M; Tong BMK; Tnay YL; Ng XR; Zhu P; Chiba S; Wang X; Wahli W; Tan NS
Cell Discov; 2018; 4():15. PubMed ID: 29619245
[TBL] [Abstract][Full Text] [Related]
3. Role of peroxisome proliferator-activated receptors gene polymorphisms in type 2 diabetes and metabolic syndrome.
Dong C; Zhou H; Shen C; Yu LG; Ding Y; Zhang YH; Guo ZR
World J Diabetes; 2015 May; 6(4):654-61. PubMed ID: 25987964
[TBL] [Abstract][Full Text] [Related]
4. Physiological functions of peroxisome proliferator-activated receptor β.
Neels JG; Grimaldi PA
Physiol Rev; 2014 Jul; 94(3):795-858. PubMed ID: 24987006
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the 'future' in dermatology therapeutics?
Gupta M; Mahajan VK; Mehta KS; Chauhan PS; Rawat R
Arch Dermatol Res; 2015 Nov; 307(9):767-80. PubMed ID: 25986745
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of a series of alkoxy-3-indolylacetic acids as peroxisome proliferator-activated receptor γ/δ agonists.
Gim HJ; Li H; Jeong JH; Lee SJ; Sung MK; Song MY; Park BH; Oh SJ; Ryu JH; Jeon R
Bioorg Med Chem; 2015 Jul; 23(13):3322-36. PubMed ID: 25982078
[TBL] [Abstract][Full Text] [Related]
7. The peroxisome proliferator-activated receptor β/δ agonist GW0742 has direct protective effects on right heart hypertrophy.
Kojonazarov B; Luitel H; Sydykov A; Dahal BK; Paul-Clark MJ; Bonvini S; Reed A; Schermuly RT; Mitchell JA
Pulm Circ; 2013 Dec; 3(4):926-35. PubMed ID: 25006409
[TBL] [Abstract][Full Text] [Related]
8. Anti-Diabetic Therapy, Heart Failure and Oxidative Stress: An Update.
Koniari I; Velissaris D; Kounis NG; Koufou E; Artopoulou E; de Gregorio C; Mplani V; Paraskevas T; Tsigkas G; Hung MY; Plotas P; Lambadiari V; Ikonomidis I
J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36012897
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective Effects of PPARβ/δ Activation against Ischemia/Reperfusion Injury in Rat Heart Are Associated with ALDH2 Upregulation, Amelioration of Oxidative Stress and Preservation of Mitochondrial Energy Production.
Papatheodorou I; Galatou E; Panagiotidis GD; Ravingerová T; Lazou A
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203800
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-185 inhibits the proliferation and migration of HaCaT keratinocytes by targeting peroxisome proliferator-activated receptor β.
Yang J; Deng P; Qi Y; Feng X; Wen H; Chen F
Exp Ther Med; 2021 Apr; 21(4):366. PubMed ID: 33732339
[TBL] [Abstract][Full Text] [Related]
11. Frontline Science: Activation of metabolic nuclear receptors restores periodontal tissue homeostasis in mice with leukocyte adhesion deficiency-1.
Kajikawa T; Wang B; Li X; Wang H; Chavakis T; Moutsopoulos NM; Hajishengallis G
J Leukoc Biol; 2020 Nov; 108(5):1501-1514. PubMed ID: 32421906
[TBL] [Abstract][Full Text] [Related]
12. PPAR
Jiang Y; Li Q; Jia M; Yan Z
Int J Hypertens; 2019; 2019():7809216. PubMed ID: 31073415
[TBL] [Abstract][Full Text] [Related]
13. Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer.
Peters JM; Kim DJ; Bility MT; Borland MG; Zhu B; Gonzalez FJ
Mol Carcinog; 2019 Sep; 58(9):1612-1622. PubMed ID: 31062422
[TBL] [Abstract][Full Text] [Related]
14. Lipid Metabolism Alteration by Endocrine Disruptors in Animal Models: An Overview.
Maradonna F; Carnevali O
Front Endocrinol (Lausanne); 2018; 9():654. PubMed ID: 30467492
[TBL] [Abstract][Full Text] [Related]
15. The PPARβ/δ agonist GW0742 modulates signaling pathways associated with cardiac myocyte growth via a non-genomic redox mechanism.
Galatou E; Kelly T; Lazou A
Mol Cell Biochem; 2014 Oct; 395(1-2):145-54. PubMed ID: 24939361
[TBL] [Abstract][Full Text] [Related]
16. Activation of PPARβ/δ protects cardiac myocytes from oxidative stress-induced apoptosis by suppressing generation of reactive oxygen/nitrogen species and expression of matrix metalloproteinases.
Barlaka E; Görbe A; Gáspár R; Pálóczi J; Ferdinandy P; Lazou A
Pharmacol Res; 2015; 95-96():102-10. PubMed ID: 25828396
[TBL] [Abstract][Full Text] [Related]
17. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes.
Burdick AD; Bility MT; Girroir EE; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Cell Signal; 2007 Jun; 19(6):1163-71. PubMed ID: 17254750
[TBL] [Abstract][Full Text] [Related]
18. Role of UCP2 in the protective effects of PPARβ/δ activation on lipopolysaccharide-induced endothelial dysfunction.
Toral M; Romero M; Jiménez R; Robles-Vera I; Tamargo J; Martínez MC; Pérez-Vizcaíno F; Duarte J
Biochem Pharmacol; 2016 Jun; 110-111():25-36. PubMed ID: 27179975
[TBL] [Abstract][Full Text] [Related]
19. Carnitine palmitoyltransferase-1 up-regulation by PPAR-β/δ prevents lipid-induced endothelial dysfunction.
Toral M; Romero M; Jiménez R; Mahmoud AM; Barroso E; Gómez-Guzmán M; Sánchez M; Cogolludo Á; García-Redondo AB; Briones AM; Vázquez-Carrera M; Pérez-Vizcaíno F; Duarte J
Clin Sci (Lond); 2015 Nov; 129(9):823-37. PubMed ID: 26253087
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
